Value of consecutive galactomannan determinations for the diagnosis and prognosis of invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary disease

References

• Maertens J, Eldere JV, Verhaegen J, . Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002; 186: 1297–1306.
   PubMed Web of Science ®Google Scholar
• Busca A, Locatelli F, Barbui A, . Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation. Transplant Proc 2006; 38: 1610–1613.
   PubMed Web of Science ®Google Scholar
• Pfeiffer C, Fine J, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42: 1417–1427.
   PubMed Web of Science ®Google Scholar
• Meersseman W, Vandecasteele SJ, Wilmer A, . Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004; 170: 621–625.
   PubMed Web of Science ®Google Scholar
• Denning DW. Aspergillosis in ‘nonimmunocompromised’ critically ill patients. Am J Respir Crit Care Med 2004; 170: 580–581.
   PubMed Web of Science ®Google Scholar
• Segal BH. Aspergillosis. N Engl J Med 2009; 360: 1870–1884.
   PubMed Web of Science ®Google Scholar
• Meersseman W, Lagrou K, Maertens J, Wijngaerden EV. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007; 45: 205–216.
   PubMed Web of Science ®Google Scholar
• Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007; 30: 782–800.
   PubMed Web of Science ®Google Scholar
• Samarakoon P, Soubani A. Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chron Respir Dis 2008; 5: 19–21.
   PubMedGoogle Scholar
• Guinea J, Torres-Narbona M, Gijon P, . Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 2010; 16: 870–877.
   PubMed Web of Science ®Google Scholar
• Muquim A, Dial S, Menzies D. Invasive aspergillosis in patients with chronic obstructive pulmonary diseases. Can Respir J 2005; 12: 199–204.
   PubMedGoogle Scholar
• Bulpa P, Dive A, Garrino M, . Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? Intensive Care Med 2001; 27: 59–67.
   PubMed Web of Science ®Google Scholar
• Ader F, Bienvenu A, Rammaert B, Nseir S. Management of invasive aspergillosis in patients with COPD: rational use of voriconazole. Int J Chron Obstruct Pulmon Dis 2009; 4: 279–287.
   PubMedGoogle Scholar
• Rello J, Esandi M, Mariscal D, . Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998; 26: 1473–1475.
   PubMed Web of Science ®Google Scholar
• Ader F, Nseir S, Berre RL, . Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect 2005; 11: 427–429.
   PubMed Web of Science ®Google Scholar
• Zhan Q, He H, Tong Z, Li F, Sun B, Wang C. Clinical features of invasive pulmonary aspergillosis in critically ill patients with chronic respiratory diseases. Zhonghua Jie He He Hu Xi Za Zhi 2008; 31: 282–286.
   PubMedGoogle Scholar
• Guinea J, Jensen J, Pelaez T, . Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of Aspergillus spp. Med Mycol 2008; 46: 575–588.
   PubMed Web of Science ®Google Scholar
• Khasawneh F, Mohamad T, Moughrabieh M, . Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome. J Crit Care 2006; 21: 322–327.
   PubMed Web of Science ®Google Scholar
• Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, . Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 2005; 9: R191–R199.
   PubMed Web of Science ®Google Scholar
• Maertens J, Buve K, Theunissen K, . Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer 2009; 115: 355–362.
   PubMed Web of Science ®Google Scholar
• Ascioglu S, Rex J, Pauw BD, . Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14.
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004; 4: 349–357.
   PubMed Web of Science ®Google Scholar
• Clemons KV, Stevens DA. Conventional or molecular measurement of Aspergillus load. Med Mycol 2009; 47(Suppl. 1): S132–137.
   Google Scholar
• Marr KA, Balajee SA, McLaughlin L, . Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004; 190: 641–649.
   PubMed Web of Science ®Google Scholar
• Vallor AC, Kirkpatrick WR, Najvar LK, . Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture. Antimicrob Agents Chemother 2008; 52: 2593–2598.
   PubMed Web of Science ®Google Scholar
• Gao X, Chen L, Hu G, Mei H. Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests. Ann Saudi Med 2010; 30: 193–197.
   PubMedGoogle Scholar